Definitive Thoracic Radiotherapy

RADIATION2 trials

Sponsors

Hunan Cancer Hospital, You Peimeng

Conditions

EGFR Uncommon MutationsNSCLC (Non-small Cell Lung Carcinoma)Number of LymphocytesRadiation-induced LymphopeniaStage IIIThymus Dosimetric

Phase 2

Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma

RecruitingNCT07314216

Hunan Cancer HospitalEGFR Uncommon Mutations, NSCLC (Non-small Cell Lung Carcinoma), Stage III

Start: 2026-06-22End: 2030-12-31Target: 15Updated: 2026-07-08

Unknown Phase

Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC

Active, not recruitingNCT07564089

You PeimengNumber of Lymphocytes, Radiation-induced Lymphopenia, Thymus Dosimetric

Start: 2026-04-10End: 2028-02-28Updated: 2026-05-04